Fundz

Americhem to acquire Noble Biomaterials

PRIVATEOct 27, 2026

Acquiring Company

Americhem

Acquired Company

Noble Biomaterials

Cuyahoga FallsManufacturingManufacturingBiotechnology

Description

Americhem announced the acquisition of Noble Biomaterials, an advanced materials company focused on antimicrobial and conductivity solutions for soft surfaces. The deal adds Noble's technologies to Americhem's global platform. The acquisition strengthens Americhem's ability to support customers from concept through production.

Who to call at Americhem, and when

When Americhem changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Americhem raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Americhem, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Americhem. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Americhem

Location

Cuyahoga Falls, Ohio, United States

About

Americhem is an innovative, technology-driven leader in the global polymer industry. Its foundation is built around delivering Performance, Solutions and Trust through close collaboration with customers. All of the company's products are backed by complete technical support that ensures quality, reliability, and value.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Americhem makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Lauren
Likely contact at this company
••••••••@••••••••

See Lauren's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Americhem's next move

Learn about Strategic plan

Frequently asked

Who acquired Noble Biomaterials?

Noble Biomaterials was acquired by Americhem, based in Cuyahoga Falls. The deal was reported on October 27, 2026. Americhem is an innovative, technology-driven leader in the global polymer industry. Its foundation is built around delivering Performance, Solutions and Trust through close collaboration with customers. Americhem is privately held and operates in Manufacturing.

When did Americhem acquire Noble Biomaterials?

Americhem's acquisition of Noble Biomaterials was reported on October 27, 2026. Americhem announced the acquisition of Noble Biomaterials, an advanced materials company focused on antimicrobial and conductivity solutions for soft surfaces. The deal adds Noble's technologies to Americhem's global platform. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Noble Biomaterials do?

Noble Biomaterials is an advanced materials company that specializes in antimicrobial and conductivity solutions for soft surface applications. Its differentiated technologies and deep specialization are being added to Americhem's global platform. It is privately held, operating in Manufacturing.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.